Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Erratum

View at publisher Summarise with VIRAT
Authors: Kelly Nugent, Lyucheng Huang, Maisa Nazzal, Amy L. Pasternak, Daniel L. Hertz
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In the article titled “Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity” [1], there is an error in the reported direction of the genetic association with severe irinotecan toxicity incidence. The article should report that presence of CES1 rs3785161 genotypes CA/CC increase severe toxicity, not genotype AA. This error is found in the abstract, results, and discussion sections. Table 2 reports the pharmacogenetic association and remains correct. The following sentences should be corrected: In the abstract, “In the exploratory analysis, CES1 rs3785161 AA was associated with an increased likelihood of severe irinotecan toxicity (37% vs 16%, p=0.034)…” should be “In the exploratory analysis, CES1 rs3785161 CA/CC was associated with an increased likelihood of severe irinotecan toxicity (37% vs 16%, p=0.034)…”. In the results, “In the secondary, exploratory analysis, CES1 rs3785161 AA increased the likelihood of severe toxicity (37% vs 16%, p=0.034)…” should be “In the secondary, exploratory analysis, CES1 rs3785161 CA/CC increased the likelihood of severe toxicity (37% vs 16%, p=0.034)…”. Lastly, in the discussion, “…an exploratory secondary analysis found evidence that CES1 rs3785161 AA and ABCG2 rs2231142 AA/AC may be risk factors for other toxicities” should read “…an exploratory secondary analysis found evidence that CES1 rs3785161 CA/CC and ABCG2 rs2231142 AA/AC may be risk factors for other toxicities”. The authors apologize for the inconvenience.

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Drug Transport and Resistance Mechanisms Drug-Induced Adverse Reactions

Publication details

Journal / source
Pharmacogenetics and Genomics
Volume
36
Issue
3
Pages
123–123
Publication date
24 March 2026
Language
EN